Advances in the Treatment of Renal Cell Carcinoma
| Advances in the Treatment of Renal Cell Carcinoma |
| Autore | Reynolds Paul |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (221 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
artesunate (ART)
autophagy biomarker biomarkers ccRCC chloroquine clear cell renal cell carcinoma cysteine cathepsin inhibitors cysteine cathepsins evolution evolutionary trajectory ferroptosis genomic signature growth inhibition hydroxychloroquine immune checkpoint inhibitors immune-based combination therapies immunotherapy individualization kidney cancer lysosome metastatic metastatic renal cell carcinoma mRCC network meta-analysis PD-L1 predictive RCC reactive oxygen species (ROS) renal cancer renal cell cancer renal cell carcinoma renal cell carcinoma (RCC) ROC-325 second line therapy soluble factors sunitib resistance TKIs Traditional Chinese Medicine (TCM) transcriptomic analysis treatment tyrosine kinase inhibitors |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557615503321 |
Reynolds Paul
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Application of Bioinformatics in Cancers
| Application of Bioinformatics in Cancers |
| Autore | Brenner J. Chad |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 online resource (418 p.) |
| Soggetto topico | Biotechnology |
| Soggetto non controllato |
activation induced deaminase
AID/APOBEC alternative splicing anti-cancer artificial intelligence bioinformatics Bioinformatics tool biomarker discovery biomarker signature biomarkers biostatistics brain brain metastases breast cancer breast cancer detection breast cancer prognosis Bufadienolide-like chemicals cancer cancer biomarker cancer biomarkers cancer CRISPR cancer modeling cancer prognosis cancer treatment cancer-related pathways cell-free DNA chemotherapy circulating tumor DNA (ctDNA) classification clinical/environmental factors colorectal cancer comorbidity score Computational Immunology concatenated deep feature copy number aberration copy number variation curation curative surgery datasets decision support systems deep learning denoising autoencoders differential gene expression analysis diseases genes DNA DNA sequence profile drug resistance epigenetics erlotinib estrogen extreme learning false discovery rate feature extraction and interpretation feature selection firehose functional analysis gefitinib gene expression analysis gene inactivation biomarkers gene loss biomarkers gene signature extraction genomic instability GEO DataSets head and neck cancer health strengthening herb hierarchical clustering analysis high-throughput analysis histopathological imaging histopathological imaging features HNSCC hormone sensitive cancers HP hTERT imaging independent prognostic power interaction intratumor heterogeneity knockoffs KRAS mutation locoregionally advanced machine learning meta-analysis methylation microarray miRNA miRNAs mitochondrial metabolism mixture of normal distributions molecular mechanism molecular subtypes Monte Carlo mortality multiple-biomarkers mutable motif mutation Neoantigen Prediction network analysis Network Analysis network pharmacology network target neurological disorders next generation sequencing observed survival interval omics omics profiles oral cancer ovarian cancer overall survival pancreatic cancer pathophysiology PD-L1 precision medicine predictive model protein R package RNA self-organizing map single-biomarkers single-cell sequencing skin cutaneous melanoma somatic mutation StAR steroidogenic enzymes survival analysis TCGA TCGA mining telomerase telomeres The Cancer Genome Atlas traditional Chinese medicine transcriptional signatures treatment de-escalation tumor tumor infiltrating lymphocytes tumor microenvironment variable selection |
| ISBN | 3-03921-789-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367743403321 |
Brenner J. Chad
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Biomarkers Used for the Diagnosis of Diseases
| Biomarkers Used for the Diagnosis of Diseases |
| Autore | Nimse Satish Balasaheb |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (120 p.) |
| Soggetto topico | Research & information: general |
| Soggetto non controllato |
amperometric immunosensors
bacteria bio-imaging biosensors biothiols bladder cancer cancer cancer markers creatinine cysteine cystinuria droplet generation electrochemical immunosensors eletrochemiluminescent immunosensors endotoxin fluorimeter GC-IMS GC-TOF-MS high-aspect-ratio microfluidic channel immune checkpoints immunosensors impedimetric immunosensors lipid A LPS machine olfaction monodisperse droplet parallelogram cross-section PD-1 PD-L1 piezo-enzymatic-reaction effect portable prostate cancer self-powered biosensor SERS silver nanorods urinary biomarkers urinary VOCs voltammetric immunosensors ZnO nanowires |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566479803321 |
Nimse Satish Balasaheb
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Immunology
| Cancer Immunology |
| Autore | Subramanian Subree |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (316 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adaptive immunity
anti-CD20 antibody anti-CTLA-4 anti-PD-1 antibody-dependent cellular cytotoxicity (ADCC) antigen presenting cells antigen-presenting cells Atypical Chemokine Receptor 4 (ACKR4) B cell aplasia BAP1 BiFab bispecific antibody cancer cancer stem cells (CSCs) cancer vaccine CAR T carcinoma CD19-CAR-T CD28 cell therapy chemo-enzymatic approach chemotherapy classical and endemic Kaposi Sarcoma colon cancer colorectal cancer combination immunotherapy CTLA-4 cytotoxicity dendritic cells differentiation DNA methylation epidemiologic studies Fab IDO inhibitor IFN-γ IL-7 IL15 immune checkpoint blockade immune checkpoint inhibitors immune checkpoints immune evasion immunomodulation immunosuppression immunotherapy indoleamine 2,3 dioxygenase 1 inhibitory CAR innate immunity interferon KIR kynurenine pathway m6A melanoma MICA/B mAb multi-state modelling n/a NK cells NKG2D organ transplantation osteoclasts PD-1 PD-L1 primary liver cancer prostate cancer resistance RNA methylation S-adenosylmethionine (SAM) sortase A systemic treatment T cells T-cell priming TCR diversity TIL treatment free interval Treg cells triple negative breast cancer tryptophan 2,3 dioxygenase 2 tumor microenvironment tumor-infiltrating lymphocytes uveal |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557349203321 |
Subramanian Subree
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cancer Nanomedicine
| Cancer Nanomedicine |
| Autore | Hoskins Clare |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (510 p.) |
| Soggetto topico | Technology: general issues |
| Soggetto non controllato |
actin
active targeting acute toxicity adsorption albumin albumin nanoparticle albumin nanoparticles anacardic acid angiogenesis anti-cancer anti-metastatic enzyme cancer therapy anti-topoisomerase activity anti-tumor immunity antibody drug conjugate (ADC) anticancer and antibacterial activity antitumor strategy apoptosis ascorbic acid BALB-neuT mice biodistribution biomimetic biomimetic core-shell nanoparticles biomimicry bleeding blood brain barrier brain tumours breast cancer cabazitaxel cancer cancer diagnosis cancer nanomedicine cancer therapy cathepsin D cathepsin L cats cell signaling cellular interaction cellular microenvironment chemico-physical functionalization chemotherapeutics chirality separation clinical status clinical translation collagen colloidal stability colorectal carcinoma combinatorial therapy copper CPMV CSCs cyclodextrins cytotoxicity diagnostics differentiated neuroblastoma dioleoylphosphatidylethanolamine DNA origami docetaxel dogs DOX doxorubicin drug combination drug delivery drug delivery system drug-gene delivery drug-in-cyclodextrin-in-liposome dual-targeting epithelial-to-mesenchymal transition EPR effect erlotinib everolimus exosomes extracellular vesicles FA-DABA-SMA flow folate folate receptor folic receptor alpha glioblastoma glioma gold nanoparticles gold nanorods graphene oxide hepatocellular carcinoma hyaluronic acid hyaluronidase hybrid nanoparticles hyperthermia hyperthermia therapy hypoxia imaging immune modulation immunosuppression immunotherapy Immunotherapy in situ vaccine in vitro in vitro anti-cancer activity integrin intra-arterial chemotherapy intracellular disruption intracranial glioma iron affinity lanthanide metal ligand lipid nanoparticles liposome liposomes loading lung cancer lymphadenectomy magnetic actuation magnetic drug targeting magnetic hyperthermia magnetic nanoparticles magnetic nanowires magnetic silica-coated iron oxide nanochains magnetometer mammary carcinoma mangiferin MDA-MB-231 melanoma membrane-wrapped mesenchymal stem cells (MSCs) Mesoporous silica nanoparticle mesoporous silica nanoparticles metabolism microbubble microfluidic mitoxantrone mixed micelle molecular imaging monoclonal antibodies multicellular tumor spheroids nano-bio interactions nano-engineered MSCs nanobiotechnology nanocarrier nanomedicine nanomedicines nanomicelles nanoparticle nanoparticles nanostructured lipid carrier nanosystems nanotechnology: bioengineering nanotherapeutics NASH near IR hyperspectral imaging NK cell-derived exosomes oncogenes oncogenic proteins organoids organotin orthotopic lung tumor model osteopontin ovarian cancer ovarian carcinomatosis oxidation-sensitive release paclitaxel pancreatic cancer parvifloron D passive targeting PD-L1 PEGylation peptidomimetics pH responsive photodynamic therapy photodynamic therapy article photothermal therapy photothermal treatment plasmonic photothermal therapy plasmonics platelet membrane PLGA poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer polydopamine nanoparticles polymeric nanoconstruct polymeric nanoparticles prostate cancer radiotherapy real-time quantitative polymerase chain reaction (qPCR) remote loading RGD peptide riboflavin secondary structure self-assembly sentinel lymph node dissection shear stress single-walled carbon nanotubes siRNA size SN38 spheroids SPION stimuli-responsive superparamagnetic iron oxide nanoparticles surgery target treatment targeted delivery targeted delivery system targeted drug delivery targeted therapy TAT peptide temoporfin theranostic nanomaterials theranostics therapeutics titanate nanotubes translational medicine triple negative breast cancer tumor microenvironment tumor spheroid disruption tumor targeting tumor vectorization tumour microenvironment tumour targeting ultrasound vectorization VEGF verteporfin viral nanoparticles vitamin B2 VX2 tumor Vδ2 T cells yet reasonably common within the subject discipline zoledronic acid β-cyclodextrin nanosponges |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557114703321 |
Hoskins Clare
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cross Talk between Lymph Node Lymphatic Endothelial Cells and T Cells in Inflammation and Cancer
| Cross Talk between Lymph Node Lymphatic Endothelial Cells and T Cells in Inflammation and Cancer |
| Autore | Silvia Della Bella |
| Pubbl/distr/stampa | Frontiers Media SA, 2017 |
| Descrizione fisica | 1 online resource (100 p.) |
| Collana | Frontiers Research Topics |
| Soggetto topico | Medicine |
| Soggetto non controllato |
Antigen Presenting Cells
Liver Injury Lymphatic Endothelial Cells Lymphatic Vasculature Lymphatic Vessels PD-L1 T cell trafficking T cells Tumor Microenvironment |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910261134703321 |
Silvia Della Bella
|
||
| Frontiers Media SA, 2017 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Marine Drug Research in China: Selected Papers from the 15-NASMD Conference
| Marine Drug Research in China: Selected Papers from the 15-NASMD Conference |
| Autore | Zhou Xuefeng |
| Descrizione fisica | 1 online resource (512 p.) |
| Soggetto topico | Medicine and Nursing |
| Soggetto non controllato |
absolute configuration
AChE inhibitory actinomycete actinomycin D actinomycin X2 adenosine monophosphate-activated protein kinase (AMPK) ADME ADMET adsorption kinetics and isotherms angiotensin-I-converting enzyme (ACE) peptide Antarctic krill (Euphausia superba) anti-glioma activity anti-inflammatory activity antiaging antibacterial antibacterial activity antibacterial properties anticancer antihyperlipidemic antimicrobial activity antimicrobial peptides antioxidant activity antitumor activity antitumor peptide apoptosis Arca inflata aromatic acids ascidian-derived fungus Aspergillus flavipes HN4-13 Aspergillus hiratsukae Aspergillus puniceus Aspergillus sclerotiorum Aspergillus sp Aspergillus terreus Aspergillus unguis biological activities butenolides butyrolactone I Caenorhabditis elegans calmodulin CDK4/6 chejuenlide chronic kidney disease clavipitacae cognitive dysfunction colorectal cancer coral-derived fungi cyclic pentapeptide cytotoxic activity cytotoxicity deep-sea actinomycetes deep-sea fungus deep-sea-derived fungus depsides depsidones Diaporthe sp drug design dyeing emodin enantiomers endothelin-1 (ET-1) enrichment eremophilane sesquiterpenoids flavonoid fluorescent properties food allergy fucoidan fucoxanthin galaxamide analogues genome mining geodin GSK3β-Nrf2-HO-1 signaling Hahella heterocornols IL-17 pathway insecticidal activity isoquinoline alkaloid LC-MS/MS Lecanicillium fusisporum lipodepsipeptide macroporous resin XAD-16 mangrove endophytic Pestalotiopsis mangrove-derived fungus MAPK signaling marine compounds marine fungi mechanism meroterpenoids metabolism methicillin-resistant Staphylococcus aureus microbial pigments microbiota microglial polarization mm-pbsa molecular docking molecular dynamics mutants NAFLD nasopharyngeal carcinoma neuroinflammation nitric oxide (NO) Nrf2 nuclear factor erythroid-2-related factor 2-mediated (Nrf2) Oceanapia osteoclast differentiation oxidative stress oxidized low-density lipoprotein oximes oyster pancreatic lipase PD-L1 Penicillium sp peptide peptidome Pestalotiopsis heterocornis pharmacokinetics pharmacophore construction pharmacophore modeling phycocyanin piericidins plasma prodiginine protein tyrosine phosphatase inhibitor pyranodipyran derivatives sclerotides Sdy-1 secondary metabolites semisynthesize sesquiterpene glycoside signaling pathway silk skipjack tuna (Katsuwonus pelamis) muscle soft-coral-derived fungus Sonneratia apetala sponge sponge-derived fungus stability Streptomyces parvulus tetramic acid derivatives Toll-like receptor 4-mediated (TLR4) transcriptome Trichoderma longibrachiatum tyrosyl DNA phosphodiesterase 1 inhibitory activities vascular endothelial cell virtual screening Wnt signaling xanthones β-catenin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Marine Drug Research in China |
| Record Nr. | UNINA-9910595071903321 |
Zhou Xuefeng
|
||
| Lo trovi qui: Univ. Federico II | ||
| ||
Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments
| Non-small Cell Lung Cancer: Current Therapies and New Targeted Treatments |
| Autore | Uchino Junji |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (258 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
adjuvant chemotherapy
biomarker chemotherapy daily practice DNA polymerase beta docetaxel EGFR-TKI endocrine disorders epidermal growth factor receptor Expanded Access Program FDG-PET genomic diagnosis glucose transporter 1 HIP1R immune checkpoint inhibitor immune checkpoint inhibitors immune-related adverse events immunotherapy interstitial lung disease KRAS lung cancer lung neoplasms meta-analysis metastasis methylation multiple cancers mutation network meta-analysis nivolumab non-small cell lung cancer non-small-cell lung cancer nonsmall cell lung cancer NSCLC nucleotide-diphosphate kinase oligometastasis osimertinib PD-1 PD-1 blockade PD-1 inhibitors PD-L1 PD-L1 expression PD-L1 inhibitors phase I/II trial platinum-based first-line predictive biomarker previously treated patients prognosis prognostic factor prognostic factors pulmonary fibrosis pulmonary pleomorphic carcinoma RAD51B methylation radiology and other imaging real-world data rechallenge recurrence responsiveness retrospective analysis RUNX1 S-1 salvage surgery sequencing stage IIIA-N2 surgery survival T790M targeted therapy TP53 mutations tumor-bearing patients tyrosine kinase inhibitors unresectable β-catenin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Non-small Cell Lung Cancer |
| Record Nr. | UNINA-9910557489703321 |
Uchino Junji
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Oncolytic Virus Immunotherapy
| Oncolytic Virus Immunotherapy |
| Autore | Marchini Antonio |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (366 p.) |
| Soggetto topico |
Clinical and internal medicine
Medicine and Nursing |
| Soggetto non controllato |
adenovirus
adoptive T cell therapy antigen-agnostic vaccination antitumor immune response arming biomarkers cancer cancer immune therapy cancer immunotherapy cancer therapy CAR T cell checkpoint inhibitor checkpoint inhibitors class I HLA clinical trials colorectal cancer combination therapy combinatory therapy CTLA-4 delivery DNA methyltransferase inhibitor (DNMTi) epigenetic silencing genetic modification glioblastoma HER2 herpes simplex virus HSV-1 immune checkpoint blockade immune checkpoint inhibitor immunoediting immunogenic cell death immunostimulatory immunosurveillance immunotherapy measles virus melanoma multi-stage n/a NDV newcastle disease virus oncogenic signaling oncolytic oncolytic adenovirus oncolytic virus oncolytic viruses pancreatic cancer pancreatic ductal adenocarcinoma parvovirus PD-1 PD-L1 personalized oncolyticvirotherapy RAS reovirus retargeted virus small molecule targeting tropism retargeting tumor tumor microenvironment type I interferon vaccination vector engineering vesicular stomatitis virus viral mimicry virotherapy αvβ6 integrin |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566462203321 |
Marchini Antonio
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases
| Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases |
| Autore | Rustum Youcef M |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 online resource (166 p.) |
| Soggetto topico | Biology, life sciences |
| Soggetto non controllato |
anticancer
anticancer agent antitumor activity apoptosis cancer cancer stem cells cell plasticity chemotherapeutics clear cell renal cell carcinoma clear-cell renal cell carcinoma microRNAs disease DNA damage DNA damage and repair EMT entosis epigenetics ER stress glutathione head and neck cancer HIF hSP56 hypoxia hypoxia-inducible factor hypoxia-inducible factors (HIFs) immune evasion isoselenourea lipid peroxidation malignant melanoma methylseleninic acid methylselenocysteine methylselenoesters miRNA mTOR inhibitors PD-L1 radiation SBP1 Se-containing nanoparticles SELENBP1 selenium selenium species selenium-binding protein 1 seleno-l-methionine STAT3 tocopherol tumor heterogeneity tumor microenvironment VEGF viability |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910346851003321 |
Rustum Youcef M
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||